We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Personalis Inc
7 own
9 watching
Current Price
$3.9
$0.86
(28.29%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
179.23M
52-Week High
12.96
52-Week Low
1.73
Average Volume
7.85M
Dividend Yield
--
P/E Ratio
--
Market Capitalization179.23M52-Week High12.9652-Week Low1.73Average Volume7.85MDividend Yield--P/E Ratio--What does the Personalis Inc do?
Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. They designed their NeXT Platform to adapt to the complex and evolving understanding of cancer, providing their biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, in contrast to many cancer panels that cover roughly 50 to 500 genes. They are also developing a complementary liquid biopsy assay that analyzes all human genes versus the more narrowly focused liquid biopsy assays that are currently available. By combining technological innovation, operational scale, and regulatory differentiation, their NeXT Platform is designed to help their customers obtain new insights into the mechanisms of response and resistance to therapy as well as new potential therapeutic targets. Their platform enhances the ability of biopharmaceutical companies to unlock the potential of conducting translational research in the clinic rather than with pre-clinical animal models or cancer cell lines. They are also planning to release a diagnostic based on their NeXT Platform that they envision being used initially by biopharmaceutical customers and clinical collaborators. Since inception, they have provided their services to more than 45 biopharmaceutical customers, including several of the largest pharmaceutical companies in the world. Personalis, Inc. were incorporated under the laws of the state of Delaware in February 2011 under the name Personalis, Inc. Their principal executive offices are located at 1330 O’Brien Drive, Menlo Park, California 94025.
Read More
How much money does Personalis Inc make?
News & Events about Personalis Inc.
Business Wire
2days ago
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the companies have signed a new agreement to continue using the Personalis NeXT...
Business Wire
2 months ago
Personalis, Inc. (Nasdaq: PSNL) today announced a collaboration with UC San Francisco (UCSF) that will deploy a personalized liquid biopsy-based research use only (RUO) assay for a study of patients with colorectal cancer. The research efforts will use Personalis NeXT Personal assay to evaluate...
Ticker Report
3 months ago
Shares of Personalis, Inc. (NASDAQ:PSNL Get Rating) have earned an average rating of Moderate Buy from the six brokerages that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have issued a ...
Business Wire
4 months ago
Personalis, Inc. (Nasdaq: PSNL) has joined with Duke University and Olink Proteomics AB to form a research collaboration to study the effects of immunotherapy on advanced gastroesophageal cancer. Specifically, the collaboration will focus on identifying composite biomarkersthose that integrate...
Business Wire
9 months ago
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the appointment of James Azzaro to the newly created position of Vice President of Diagnostic Sales. This appointment supports the companys objective to accelerate expansion into the clinical...
Frequently Asked Questions
Frequently Asked Questions
What is Personalis Inc share price today?
Can Indians buy Personalis Inc shares?
How can I buy Personalis Inc shares from India?
Can Fractional shares of Personalis Inc be purchased?
What are the documents required to start investing in Personalis Inc stocks?
What is today’s traded volume of Personalis Inc?
What is today’s market capitalisation of Personalis Inc?
What is the 52-Week High and Low Range of Personalis Inc?
What percentage is Personalis Inc down from its 52-Week High?
What percentage is Personalis Inc up from its 52-Week Low?
Current Price
$3.9
$0.86
(28.29%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.